These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26118578)

  • 21. Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.
    Khakoo SI; Coles CJ; Armstrong JS; Barry RE
    J Clin Gastroenterol; 1995 Apr; 20(3):244-7. PubMed ID: 7797836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute liver failure].
    Friebe M; Kindler U
    Internist (Berl); 1998 Sep; 39(9):999-1000. PubMed ID: 9788129
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.
    Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Sarganas G; Kreutz R; Garbe E
    Br J Clin Pharmacol; 2015 Jun; 79(6):988-99. PubMed ID: 25444550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Campbell GA; Rosner MH
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1852-60. PubMed ID: 18684895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
    Payancé A; Scotto B; Perarnau JM; de Muret A; Bacq Y
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):e109-13. PubMed ID: 23910059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fulminant Budd-Chiari syndrome due to ecstasy.
    Taş A; Kara B; Yılmaz C; Suat Yalçın M; Dilek O; Olmez S; Saritas B
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):e12-e13. PubMed ID: 27459877
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").
    Greene SL; Dargan PI; O'connor N; Jones AL; Kerins M
    Am J Emerg Med; 2003 Mar; 21(2):121-4. PubMed ID: 12671812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine.
    Nie XH; Han T; Ha FU; Liang N; Wang SH; Zhu ZY; Xiang HL
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1142-50. PubMed ID: 24817287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute liver failure caused by Ecstasy].
    Ibrányi E; Schönléber J
    Orv Hetil; 2003 Jul; 144(29):1455-6. PubMed ID: 12939867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and toxicological evaluation of fatal poisoning with amphetamine derivative--MDMA, ecstasy (3,4-methylenedioxymethamphetamine)].
    Lukasik-Głebocka M; Wachowiak R; Kostrzewa A; Karlikowski M; Mańkowski W; Kołowski J
    Przegl Lek; 2004; 61(4):410-3. PubMed ID: 15521617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute and long-term effects of ecstasy].
    Salzmann J; Marie-Claire C; Noble F
    Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ecstasy-induced fulminant hepatic failure and emergency liver transplantation].
    Carrión JA; Escorsell A; Nogué S; Mas A
    Med Clin (Barc); 2003 Jun; 121(3):118-9. PubMed ID: 12855141
    [No Abstract]   [Full Text] [Related]  

  • 34. Two ecstasy-induced myocardial infarctions during a three month period in a young man.
    Sadeghian S; Darvish S; Shahbazi S; Mahmoodian M
    Arch Iran Med; 2007 Jul; 10(3):409-12. PubMed ID: 17604486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic and hematological complications following ecstasy usage].
    Shibolet O; Kalish Y; Gillis S; Ilan Y
    Harefuah; 2001 Oct; 140(10):911-4, 991. PubMed ID: 11681122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults].
    Claridge LC; Eksteen B; Smith A; Shah T; Holt AP
    Praxis (Bern 1994); 2011 Jul; 100(15):923-6. PubMed ID: 21792808
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute liver damage after using ecstasy].
    Shiloach E; Zecler E; Horowiz M; Scapa E
    Harefuah; 1998 Feb; 134(4):266-9, 335. PubMed ID: 10909502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced liver injury associated with ezetimibe therapy.
    Liu Q; Tobias H; Petrovic LM
    Dig Dis Sci; 2007 Feb; 52(2):602-5. PubMed ID: 17219067
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.